ID   CIB1_RAT                Reviewed;         191 AA.
AC   Q9R010; Q5BKA8;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 161.
DE   RecName: Full=Calcium and integrin-binding protein 1;
DE            Short=CIB;
DE   AltName: Full=Calmyrin;
DE   AltName: Full=DNA-PKcs-interacting protein;
DE   AltName: Full=Kinase-interacting protein;
DE            Short=KIP;
GN   Name=Cib1; Synonyms=Cib, Kip, Prkdcip;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10523297; DOI=10.1093/emboj/18.20.5528;
RA   Kauselmann G., Weiler M., Wulff P., Jessberger S., Konietzko U.,
RA   Scafidi J., Staubli U., Bereiter-Hahn J., Strebhardt K., Kuhl D.;
RT   "The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and
RT   integrin-binding protein and are regulated dynamically with synaptic
RT   plasticity.";
RL   EMBO J. 18:5528-5539(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, INTERACTION WITH TAS1R2, MYRISTOYLATION AT GLY-2, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18627437; DOI=10.1111/j.1471-4159.2008.05563.x;
RA   Hennigs J.K., Burhenne N., Staehler F., Winnig M., Walter B., Meyerhof W.,
RA   Schmale H.;
RT   "Sweet taste receptor interacting protein CIB1 is a general inhibitor of
RT   InsP3-dependent Ca2+ release in vivo.";
RL   J. Neurochem. 106:2249-2262(2008).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=20639889; DOI=10.1038/nm.2181;
RA   Heineke J., Auger-Messier M., Correll R.N., Xu J., Benard M.J., Yuan W.,
RA   Drexler H., Parise L.V., Molkentin J.D.;
RT   "CIB1 is a regulator of pathological cardiac hypertrophy.";
RL   Nat. Med. 16:872-879(2010).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21215777; DOI=10.1016/j.bbamcr.2010.12.023;
RA   Sobczak A., Debowska K., Blazejczyk M., Kreutz M.R., Kuznicki J., Wojda U.;
RT   "Calmyrin1 binds to SCG10 protein (stathmin2) to modulate neurite
RT   outgrowth.";
RL   Biochim. Biophys. Acta 1813:1025-1037(2011).
CC   -!- FUNCTION: Calcium-binding protein that plays a role in the regulation
CC       of numerous cellular processes, such as cell differentiation, cell
CC       division, cell proliferation, cell migration, thrombosis, angiogenesis,
CC       cardiac hypertrophy and apoptosis. Involved in bone marrow
CC       megakaryocyte differentiation by negatively regulating thrombopoietin-
CC       mediated signaling pathway. Participates in the endomitotic cell cycle
CC       of megakaryocyte, a form of mitosis in which both karyokinesis and
CC       cytokinesis are interrupted. Plays a role in integrin signaling by
CC       negatively regulating alpha-IIb/beta3 activation in thrombin-stimulated
CC       megakaryocytes preventing platelet aggregation. Up-regulates PTK2/FAK1
CC       activity, and is also needed for the recruitment of PTK2/FAK1 to focal
CC       adhesions; it thus appears to play an important role in focal adhesion
CC       formation. Positively regulates cell migration on fibronectin in a
CC       CDC42-dependent manner, the effect being negatively regulated by PAK1.
CC       Functions as a negative regulator of stress activated MAP kinase (MAPK)
CC       signaling pathways. Down-regulates inositol 1,4,5-trisphosphate
CC       receptor-dependent calcium signaling. Involved in sphingosine kinase
CC       SPHK1 translocation to the plasma membrane in a N-myristoylation-
CC       dependent manner preventing TNF-alpha-induced apoptosis. Regulates
CC       serine/threonine-protein kinase PLK3 activity for proper completion of
CC       cell division progression. Plays a role in microtubule (MT) dynamics
CC       during neuronal development; disrupts the MT depolymerization activity
CC       of STMN2 attenuating NGF-induced neurite outgrowth and the MT
CC       reorganization at the edge of lamellipodia. Promotes cardiomyocyte
CC       hypertrophy via activation of the calcineurin/NFAT signaling pathway.
CC       Stimulates calcineurin PPP3R1 activity by mediating its anchoring to
CC       the sarcolemma. In ischemia-induced (pathological or adaptive)
CC       angiogenesis, stimulates endothelial cell proliferation, migration and
CC       microvessel formation by activating the PAK1 and ERK1/ERK2 signaling
CC       pathway. Promotes also cancer cell survival and proliferation. May
CC       regulate cell cycle and differentiation of spermatogenic germ cells,
CC       and/or differentiation of supporting Sertoli cells (By similarity).
CC       Forms a complex with TMC6/EVER1 and TMC8/EVER2 in lymphocytes and
CC       keratynocytes where CIB1 stabilizes TMC6 and TMC8 levels and
CC       reciprocally (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q99828, ECO:0000269|PubMed:18627437}.
CC   -!- SUBUNIT: Monomer. Interacts with the heterodimeric integrin alpha-
CC       IIb/beta3 (ITGA2B-ITGB3). Interacts with ITGA2B (via cytoplasmic
CC       domain); the interaction is direct and calcium-dependent. Interacts
CC       with the protein kinases PLK2/SNK and PRKDC (via the region immediately
CC       upstream of the kinase domain). Interacts with PLK3; the interaction
CC       inhibits PLK3 kinase activity. Interacts with PSEN2. Interacts (via C-
CC       terminus) with F8. Interacts with NBR1 (via C-terminus). Interacts with
CC       FEZ1 (via C-terminus). Interacts with UBR5 (via C-terminus); the
CC       interaction is sensitive to DNA damage, and may target CIB1 for
CC       ubiquitin-mediated degradation. Interacts with IFI6; the interaction is
CC       direct. Interacts with BCL2. Interacts with ITPR3; the interaction
CC       occurs in a calcium dependent manner. Interacts with PTK2/FAK1.
CC       Interacts with MAP3K5; the interaction inhibits MAP3K5 activation by
CC       phosphorylation, and its subsequent interaction with TRAF2. Interacts
CC       (via C-terminal region) with STMN2 (via the N-terminal region); the
CC       interaction is direct, occurs in a calcium-dependent manner and
CC       attenuates the STMN2-induced neurite outgrowth inhibition. Interacts
CC       with SPHK1, the interaction occurs in a calcium-dependent manner.
CC       Interacts with ITGA2B (via C-terminal cytoplasmic tail); the
CC       interaction occurs upon platelet aggregation and is
CC       stabilized/increased in a calcium and magnesium-dependent manner.
CC       Interacts with PAK1 (via N-terminal region); the interaction is direct
CC       and occurs in a calcium-dependent manner. Interacts with RAC3 (via C-
CC       terminal region); the interaction induces their association with the
CC       cytoskeleton upon alpha-IIb/beta3 integrin-mediated adhesion. Interacts
CC       with ITGA5 and ITGAV. Interacts with MYO1C. Interacts with ITGA2B (via
CC       C-terminal cytoplasmic tail region). Interacts (via C-terminal region)
CC       with PPP3R1; the interaction increases upon cardiomyocytes hypertrophy.
CC       Interacts with CACNA1C; the interaction increases upon cardiomyocytes
CC       hypertrophy (By similarity). Interacts with TAS1R2 (via C-terminus);
CC       this interaction is independent of the myristoylation state of CIB1.
CC       Interacts and forms a complex with TMC6 and TMC8; the interaction
CC       stabilizes each component of the complex (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q99828, ECO:0000269|PubMed:18627437}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99828}; Lipid-
CC       anchor {ECO:0000250|UniProtKB:Q99828}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:Q99828}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q99828}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:Q99828}. Cell projection, ruffle membrane
CC       {ECO:0000250|UniProtKB:Q99828}. Cell projection, filopodium tip
CC       {ECO:0000250|UniProtKB:Q99828}. Cell projection, growth cone
CC       {ECO:0000250|UniProtKB:Q99828}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:Q99828}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q99828}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q99828}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:Q99828}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q99828}. Nucleus
CC       {ECO:0000250|UniProtKB:Q99828}. Cell projection, neuron projection
CC       {ECO:0000250|UniProtKB:Q99828}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q99828}. Note=Colocalized with PPP3R1 at the
CC       cell membrane of cardiomyocytes in the hypertrophic heart (By
CC       similarity). Colocalized with NBR1 to the perinuclear region.
CC       Colocalizes with TAS1R2 in apical regions of taste receptor cells.
CC       Colocalized with RAC3 in the perinuclear area and at the cell
CC       periphery. Colocalized with PAK1 within membrane ruffles during cell
CC       spreading upon readhesion to fibronectin. Redistributed to the
CC       cytoskeleton upon platelet aggregation. Translocates from the cytosol
CC       to the plasma membrane in a calcium-dependent manner. Colocalized with
CC       PLK3 at centrosomes in ductal breast carcinoma cells. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in cardiomyocytes and neurons (at protein
CC       level). Expressed during early neural development.
CC       {ECO:0000269|PubMed:20639889, ECO:0000269|PubMed:21215777}.
CC   -!- DOMAIN: The EF-hands may also bind magnesium ions in the presence of
CC       high Mg(2+) levels and low Ca(2+) levels. {ECO:0000250}.
CC   -!- MISCELLANEOUS: The binding of either calcium or magnesium significantly
CC       increases the structural stability of the protein in comparison to apo-
CC       CIB (calcium- and magnesium-free form). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF136585; AAF08368.1; -; mRNA.
DR   EMBL; BC091143; AAH91143.1; -; mRNA.
DR   RefSeq; NP_112407.1; NM_031145.1.
DR   AlphaFoldDB; Q9R010; -.
DR   SMR; Q9R010; -.
DR   BioGRID; 249681; 2.
DR   IntAct; Q9R010; 2.
DR   STRING; 10116.ENSRNOP00000047025; -.
DR   iPTMnet; Q9R010; -.
DR   PhosphoSitePlus; Q9R010; -.
DR   PaxDb; 10116-ENSRNOP00000047025; -.
DR   Ensembl; ENSRNOT00055014213; ENSRNOP00055011404; ENSRNOG00055008386.
DR   Ensembl; ENSRNOT00060007234; ENSRNOP00060005491; ENSRNOG00060004294.
DR   Ensembl; ENSRNOT00065052657; ENSRNOP00065043283; ENSRNOG00065030508.
DR   GeneID; 81823; -.
DR   KEGG; rno:81823; -.
DR   UCSC; RGD:620133; rat.
DR   AGR; RGD:620133; -.
DR   CTD; 10519; -.
DR   RGD; 620133; Cib1.
DR   VEuPathDB; HostDB:ENSRNOG00000033498; -.
DR   eggNOG; KOG0034; Eukaryota.
DR   HOGENOM; CLU_061288_6_1_1; -.
DR   InParanoid; Q9R010; -.
DR   OrthoDB; 5472814at2759; -.
DR   PhylomeDB; Q9R010; -.
DR   TreeFam; TF313865; -.
DR   PRO; PR:Q9R010; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000033498; Expressed in jejunum and 20 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0071944; C:cell periphery; ISS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:HGNC-UCL.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:HGNC-UCL.
DR   GO; GO:0032433; C:filopodium tip; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:HGNC-UCL.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISS:HGNC-UCL.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISS:HGNC-UCL.
DR   GO; GO:0008427; F:calcium-dependent protein kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0043495; F:protein-membrane adaptor activity; ISO:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; ISS:HGNC-UCL.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; ISS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; ISS:HGNC-UCL.
DR   GO; GO:0007113; P:endomitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045653; P:negative regulation of megakaryocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0007026; P:negative regulation of microtubule depolymerization; ISS:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0030220; P:platelet formation; ISS:UniProtKB.
DR   GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IMP:BHF-UCL.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:2000256; P:positive regulation of male germ cell proliferation; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0051302; P:regulation of cell division; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0002931; P:response to ischemia; ISS:UniProtKB.
DR   GO; GO:0007286; P:spermatid development; ISS:UniProtKB.
DR   GO; GO:0038163; P:thrombopoietin-mediated signaling pathway; ISS:UniProtKB.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 2.
DR   InterPro; IPR051433; CIBP.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR45791; CALCIUM AND INTEGRIN BINDING FAMILY MEMBER 2; 1.
DR   PANTHER; PTHR45791:SF3; CALCIUM AND INTEGRIN-BINDING PROTEIN 1; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Angiogenesis; Apoptosis; Calcium; Cell adhesion; Cell cycle; Cell division;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; Differentiation;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Myristate; Nucleus;
KW   Reference proteome; Repeat; Spermatogenesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..191
FT                   /note="Calcium and integrin-binding protein 1"
FT                   /id="PRO_0000073533"
FT   DOMAIN          103..138
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          148..183
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         116
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         118
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         120
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         122
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         127
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         161
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         163
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         165
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         167
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         172
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:18627437"
SQ   SEQUENCE   191 AA;  21800 MW;  3B00B0228879FCC7 CRC64;
     MGGSGSRLSK ELLAEYQDLT FLTKQEILLA HRRFCELLPP EHRTVEESLH TRVSFEQILS
     LPELKANPFK ERICMVFSTS PTRDSLSFED FLDLLSVFSD TATPDIKSHY AFRIFDFDDD
     GTLDREDLSR LVNCLTGEGE DTRLSASEMK QLIDNILEES DIDRDGTINL SEFQHVISRS
     PDFASSFKIV L
//
